Clinicians’ attitude to doublet plus anti-EGFR versus triplet plus bevacizumab as first line treatment in left-sided RAS and BRAF wild-type metastatic colorectal cancer patients: a multicentre, “real-life”, case-control study

2021 ◽  
Author(s):  
Alessandro Parisi ◽  
Giampiero Porzio ◽  
Katia Cannita ◽  
Olga Venditti ◽  
Antonio Avallone ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Case Control Study ◽  
Real Life ◽  
Case Control ◽  
Line Treatment ◽  
Wild Type ◽  
First Line ◽  
Colorectal Cancer Patients ◽  
Control Study ◽  
First Line Treatment

scholarly journals Nevirapine and tuberculosis predict first-line treatment failure in HIV patients in Indonesia: Case-control study

2020 ◽  
Vol 60 ◽  
pp. 56-60
Author(s):  
Yanri Wijayanti Subronto ◽  
Nur Aini Kusmayanti ◽  
Albarisa Shobry Abdalla ◽  
Prenaly Dwisthi Sattwika
Keyword(s):  
Treatment Failure ◽  
Case Control Study ◽  
Case Control ◽  
Line Treatment ◽  
First Line ◽  
Hiv Patients ◽  
Control Study ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document